Introduction/Background Anti-VEGF Dosing Regiments: Review of the Pertinent Studies Comparing the Anti-VEGF Dosing Strategies Conclusions References While ...
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
Familial exudative vitreoretinopathy (FEVR) was first described by Criswick and Schepens. 1 It is a rare disorder of retinal blood vessel development principally affecting retinal angiogenesis, ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- A multitargeted anti-VEGF therapy achieved ...
Please provide your email address to receive an email when new articles are posted on . Genotypes exhibit different patterns of microvascular abnormalities. OCT angiography can identify these ...
Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population
Purpose To study the prevalence, the clinical features, and the visual prognosis without treatment of polypoidal choroidal vasculopathy (PCV) in a large series of Greek patients presenting with ...
The mortality of coronavirus disease 2019 (COVID-19) is strongly correlated with pulmonary vascular pathology accompanied by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ...
Aflibercept yielded positive anatomic results in cases of exudative age-related macular degeneration that were resistant to ranibizumab or bevacizumab, according to a study. The retrospective study ...
This item is openly available as part of an Open JSTOR Collection. For terms of use, please refer to our Terms & Conditions. The American Journal of Nursing This ...
The Commission on Acute Respiratory Diseases is again calling attention to a group of acute upper-respiratory-tract infections of unknown origin that it is important to differentiate from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results